Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules

被引:207
作者
Ma, Cindy S. [1 ]
Nichols, Kim E.
Tangye, Stuart G.
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
immunodeficiency; autoimmunity; intracellular signaling; Fyn; humoral immunity;
D O I
10.1146/annurev.immunol.25.022106.141651
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SAP (SLAM-associated protein) was identified in 1998 as an adaptor molecule involved in the intracellular signaling pathways elicited through the cell surface receptor SLAM and as the protein defective in the human immunodeficiency X-linked lymphoproliferative disease (XLP). During the past eight years, it has been established that the SLAM family of cell surface receptors (SLAM, 2B4, NTB-A, Ly9, CD84) and the SAP family of adaptors (SAP, EAT-2, ERT) play critical roles in lymphocyte development, differentiation, and acquisition of effector functions. Studies of these proteins have shown unexpected roles in cytokine production by T cells and myeloid cells, T cell-dependent humoral immune responses, NK cell-mediated cytotoyicity, and NK T cell development. This review highlights recent findings that have improved our understanding of the roles of the SLAM and SAP families of molecules in immune regulation and discusses how perturbations in the signaling pathways involving these proteins can result in different disease states.
引用
收藏
页码:337 / 379
页数:43
相关论文
共 201 条
  • [1] Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene Sap
    Al-Alem, U
    Li, CL
    Forey, N
    Relouzat, F
    Fondanèche, MC
    Tavtigian, SV
    Wang, ZQ
    Latour, S
    Yin, L
    [J]. BLOOD, 2005, 106 (06) : 2069 - 2075
  • [2] DEFECTIVE NATURAL KILLING ACTIVITY BUT RETENTION OF LYMPHOCYTE-MEDIATED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN PATIENTS WITH THE X-LINKED LYMPHOPROLIFERATIVE SYNDROME
    ARGOV, S
    JOHNSON, DR
    COLLINS, M
    KOREN, HS
    LIPSCOMB, H
    PURTILO, DT
    [J]. CELLULAR IMMUNOLOGY, 1986, 100 (01) : 1 - 9
  • [3] NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions
    Assarsson, E
    Kambayashi, T
    Schatzle, JD
    Cramer, SO
    von Bonin, A
    Jensen, PE
    Ljunggren, HG
    Chambers, BJ
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (01) : 174 - 180
  • [4] FATAL INFECTIOUS-MONONUCLEOSIS IN A FAMILY
    BAR, RS
    DELOR, CJ
    CLAUSEN, KP
    HURTUBISE, P
    HENLE, W
    HEWETSON, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (07) : 363 - 367
  • [5] Persistent γ-herpesvirus infections:: What can we learn from an experimental mouse model?
    Blackman, MA
    Flaño, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) : F29 - F32
  • [6] Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
    Bloch-Queyrat, C
    Fondanèche, MC
    Chen, RY
    Yin, L
    Relouzat, F
    Veillette, A
    Fischer, A
    Latour, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (01) : 181 - 192
  • [7] Bottino C, 2000, EUR J IMMUNOL, V30, P3718
  • [8] GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease
    Bottino, C
    Falco, M
    Parolini, S
    Marcenaro, E
    Augugliaro, R
    Sivori, S
    Landi, E
    Biassoni, R
    Notarangelo, LD
    Moretta, L
    Moretta, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) : 235 - 246
  • [9] Cutting edge: Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family
    Bouchon, A
    Cella, M
    Grierson, HL
    Cohen, JI
    Colonna, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (10) : 5517 - 5521
  • [10] 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
    Brown, MH
    Boles, K
    van der Merwe, PA
    Kumar, V
    Mathew, PA
    Barclay, AN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2083 - 2090